β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial
Conclusions
β-blocker therapy after CABG is not associated with reductions in angina or cardiovascular events in low-risk patients with preserved LVEF, and may not be systematically indicated in such patients.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Accupril | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cholesterol | Coronary Artery Bypass Graft | Heart | Heart Attack | Heart Failure | Hospital Management | Quinapril | Statin Therapy | Stroke